We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Vancouver-based RS Medical was handed a 483 following a February inspection that found CAPA procedures and validation activities lacking. The company manufactures electrotherapy pain products. Read More
In an SEC filing last month, Zimmer Biomet had hinted at a warning letter but revealed little details about the exact nature of the deficiencies uncovered at the firm’s facility in Montreal, Canada. Read More
The Centers for Medicare & Medicaid Services imposed sanctions on Theranos following a litany of quality control failures for the blood testing company. Read More
The FDA has clarified expectations on unique device identifiers, which must appear in two forms on device labels and packages: an easily readable plain-text form and an automatic identification and data capture technology form. Read More
The EU’s new medical device regulations will have far-reaching implications for manufacturing and supply chain operations, and the least of which are increased roles and oversight from notified bodies that will directly impact quality management systems. Read More
The FDA found process validation, medical device reporting and other quality system failures at Biotronik’s Berlin facility during a recent inspection. Read More
Japan’s Mitaka Kohki failed to establish design control procedures, CAPA procedures, equipment calibration procedures, and documentation was found lacking for numerous critical processes during an inspection of the Tokyo-based facility. Read More
TriMed, a maker of implantable bone fixation systems, failed to report a device failure that required surgery to remove the device, according to an FDA warning letter. Read More